CDK12 and cancer: This study found that loss of CDK12 in human cancers globally increases IPA, resulting in a decrease in normal distal polyadenylation and the production of aberrant mRNAs30,31, which is a detailed mechanism by which CDK12 regulates the expression of DDR and HR genes, and CDK12 mutation potentially drives tumorigenesis.